Clinical correlation between adenosine deaminase activity and pre-eclampsia severity

Journal of International Medical Research

Volumn 34, Issue 3, 2006, Pages 247-255

  Kafkasli, A ^a   Karabulut, A B ^a   Atmaca, R ^a   Laurini, R ^b  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenosine deaminase; Fetus; Placenta; Pre eclampsia

Indexed keywords

ADENOSINE DEAMINASE;

ADULT; APGAR SCORE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MOTHER FETUS RELATIONSHIP; PARITY; PLACENTA; PREECLAMPSIA; SPECTROPHOTOMETRY; STUDENT T TEST; SYSTOLIC BLOOD PRESSURE; UMBILICAL CORD BLOOD;

EID: 33745937662     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000603400303     Document Type: Article

References (30)

1. Sibai BM: Preeclampsia: an inflammatory syndrome? Am J Obstet Gynecol 2004; 191: 1061-1062.
2. Lala PK, Chakraborty C: Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta 2003; 24: 575-587.
3. Redman CWG, Sargent IL: Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 2003; 24 (Suppl A): S21-S27.
4. Abrahams VM, Kim YM, Straszewski SL, Romero R, Mor G: Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol 2004; 51: 275-282.
5. Sargent IL, Germain SJ, Sacks GP, Kumar S, Redman CWG: Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol 2003; 59: 153-160.
6. Faas MM, Schuiling GA, Baller JFW, Visscher CA, Bakker WW: A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994; 171: 158-164.
7. Adams A, Harkness RA: Adenosine deaminase activity in thymus and human tissues. Clin Exp Immunol 1976; 26: 647-649.
8. Koehler LH, Benz EJ: Serum adenosine deaminase: methodology and clinical applications. Clin Chem 1962; 8: 133-140.
9. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, et al: Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 2001; 21: 105-128.
10. Gakis C: Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 1996; 9: 632-633.
11. Conlon BA, Law WR: Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses. Clin Exp Immunol 2004; 138: 14-20.
12. Yoneyama Y, Sawa R, Suzuki S, Otsubo Y, Miura A, Kuwabara Y, et al: Serum adenosine deaminase activity in women with pre-eclampsia. Gynecol Obstet Invest 2002; 54: 164-167.
13. Yoneyama Y, Sawa R, Suzuki S, Doi D, Yoneyama K, Otsubo Y, et al: Relationship between plasma malondialdehyde levels and adenosine deaminase activities in pre-eclampsia. Clin Chim Acta 2002; 322: 169-173.
14. Kato H, Yoneyama Y, Araki T: Fetal plasma lipid peroxide levels in pregnancies complicated by preeclampsia. Gynecol Obstet Invest 1997; 43: 158-161.
15. Davidge ST, Signorella AP, Lykins DL, Gilmour CH, Roberts JM: Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol 1996; 175: 1301-1306.
16. Friedman SA, Schiff E, Emeis JJ, Dekker GA, Kao L, Sibai BM: Fetal plasma levels of cellular fibronectin as a measure of fetal endothelial involvement in preeclampsia. Obstet Gynecol 1997; 89: 46-48.
17. ACOG Committee on Practice Bulletins - Obstetrics: diagnosis and management of preeclampsia and eclampsia. ACOG practice bulletin no. 33. Obstet Gynecol 2002; 99: 159-167.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
19. Giusti G, Golonti B: Colorimetric method. In: Methods of Enzymatic Analysis (Bergmeyer HU, ed). Weinheim: Verlag Chemie, 1984; pp315-323.
20. Karabulut AB, Kafkasli A, Burak F, Gozukara EM: Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem Funct 2005; 23: 279-283.
21. Jaqueti J, Martinez-Hernandez D, Hernandez-Garcia R, Navarro-Gallar F, Arenas-Barbero J: Adenosine deaminase in pregnancy serum. Clin Chem 1990; 36: 2144.
22. Suzuki S, Yoneyama Y, Sawa R, Araki T: Relation between maternal serum adenosine deaminase and plasma adenosine levels in twin pregnancies. Clin Biochem 2002; 35: 417-419.
23. Yoneyama Y, Suzuki S, Sawa R, Otsubo Y, Power GG, Araki T: Plasma adenosine levels increase in women with normal pregnancies. Am J Obstet Gynecol 2000; 182: 1200-1203.
24. Yoneyama Y, Sawa R, Suzuki S, Miura A, Kobayashi H, Doi D, et al: Relation between adenosine deaminase activities and cytokine-producing T cells in women with preeclampsia. Clin Biochem 2002; 35: 303-306.
25. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353-356.
26. Casey ML, Cox SM, Word RA, MacDonald PC: Cytokines and infection-induced preterm labour. Reprod Fertil Dev 1990; 2: 499-509.
27. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP: Expression of inflammatory cytokines in placentas from women with pre-eclampsia. J Clin Endocrinol Metab 2001; 86: 2505-2512.
28. Merviel P, Carbillon L, Challier IC, Rabreau M, Beaufils M, Uzan S: Pathophysiology of preeclampsia: links with implantation disorders. Eur J Obstet Gynecol Reprod Biol 2004; 115: 134-147.
29. Saito S, Sakai M: Thl/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59: 161-173.
30. Roberts JM, Lain KY: Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002; 23: 359-372.